Cargando…

Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles

BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuyama, Kohei, Sun, Hui, Igarashi, Yasuyuki, Monde, Kenji, Hirase, Takumi, Nakayama, Masato, Makino, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528138/
https://www.ncbi.nlm.nih.gov/pubmed/36184615
http://dx.doi.org/10.1186/s13195-022-01073-w
_version_ 1784801245576298496
author Yuyama, Kohei
Sun, Hui
Igarashi, Yasuyuki
Monde, Kenji
Hirase, Takumi
Nakayama, Masato
Makino, Yoichi
author_facet Yuyama, Kohei
Sun, Hui
Igarashi, Yasuyuki
Monde, Kenji
Hirase, Takumi
Nakayama, Masato
Makino, Yoichi
author_sort Yuyama, Kohei
collection PubMed
description BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs) are nanosized membrane vesicles released from a variety of cells and play important roles in cell–cell communication. Neuron-derived and ganglioside-enriched EVs capture amyloid-ß protein, a major AD agent, and transport it into glial cells for degradation; this suggests that EVs influence Aß accumulation in the brain. EV heterogeneity, however, requires the use of a highly sensitive technique for measuring specific EVs in biofluid. In this study, immuno-digital invasive cleavage assay (idICA) was developed for quantitating target-intact EVs. METHODS: EVs were captured onto ganglioside GM1-specific cholera toxin B subunit (CTB)-conjugated magnetic beads and detected with a DNA oligonucleotide-labeled Aß antibody. Fluorescence signals for individual EVs were then counted using an invasive cleavage assay (ICA). This idICA examines the Aß-bound and GM1-containing EVs isolated from the culture supernatant of human APP-overexpressing N2a (APP-N2a) cells and APP transgenic mice sera. RESULTS: The idICA quantitatively detected Aß-bound and GM1-containing EVs isolated from culture supernatants of APP-N2a cells and sera of AD model mice. The idICA levels of Aß-associated EVs in blood gradually increased from 3- to 12-month-old mice, corresponding to the progression of Aß accumulations in the brain of AD model mice. CONCLUSIONS: The present findings suggest that peripheral EVs harboring Aß and GM1 reflect Aß burden in mice. The idICA is a valuable tool for easy quantitative detection of EVs as an accessible biomarker for preclinical AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01073-w.
format Online
Article
Text
id pubmed-9528138
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95281382022-10-04 Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles Yuyama, Kohei Sun, Hui Igarashi, Yasuyuki Monde, Kenji Hirase, Takumi Nakayama, Masato Makino, Yoichi Alzheimers Res Ther Research BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs) are nanosized membrane vesicles released from a variety of cells and play important roles in cell–cell communication. Neuron-derived and ganglioside-enriched EVs capture amyloid-ß protein, a major AD agent, and transport it into glial cells for degradation; this suggests that EVs influence Aß accumulation in the brain. EV heterogeneity, however, requires the use of a highly sensitive technique for measuring specific EVs in biofluid. In this study, immuno-digital invasive cleavage assay (idICA) was developed for quantitating target-intact EVs. METHODS: EVs were captured onto ganglioside GM1-specific cholera toxin B subunit (CTB)-conjugated magnetic beads and detected with a DNA oligonucleotide-labeled Aß antibody. Fluorescence signals for individual EVs were then counted using an invasive cleavage assay (ICA). This idICA examines the Aß-bound and GM1-containing EVs isolated from the culture supernatant of human APP-overexpressing N2a (APP-N2a) cells and APP transgenic mice sera. RESULTS: The idICA quantitatively detected Aß-bound and GM1-containing EVs isolated from culture supernatants of APP-N2a cells and sera of AD model mice. The idICA levels of Aß-associated EVs in blood gradually increased from 3- to 12-month-old mice, corresponding to the progression of Aß accumulations in the brain of AD model mice. CONCLUSIONS: The present findings suggest that peripheral EVs harboring Aß and GM1 reflect Aß burden in mice. The idICA is a valuable tool for easy quantitative detection of EVs as an accessible biomarker for preclinical AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01073-w. BioMed Central 2022-10-03 /pmc/articles/PMC9528138/ /pubmed/36184615 http://dx.doi.org/10.1186/s13195-022-01073-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yuyama, Kohei
Sun, Hui
Igarashi, Yasuyuki
Monde, Kenji
Hirase, Takumi
Nakayama, Masato
Makino, Yoichi
Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title_full Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title_fullStr Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title_full_unstemmed Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title_short Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
title_sort immuno-digital invasive cleavage assay for analyzing alzheimer’s amyloid ß-bound extracellular vesicles
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528138/
https://www.ncbi.nlm.nih.gov/pubmed/36184615
http://dx.doi.org/10.1186/s13195-022-01073-w
work_keys_str_mv AT yuyamakohei immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT sunhui immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT igarashiyasuyuki immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT mondekenji immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT hirasetakumi immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT nakayamamasato immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles
AT makinoyoichi immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles